Open-Loop Insulin Delivery Adjustment Using Closed-Loop History

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional medicament delivery devices operating in an open loop manner often result in sub-optimal dosage selection by users, leading to less than optimal glucose control and increased risk of hypoglycemia due to underestimated insulin needs.

Innovation Solution

A medicament delivery device that adjusts medicament delivery amounts in open loop mode based on an average delivery history from closed loop mode, using a processor to calculate and display suggested changes or automatically adjust dosages to align with closed loop averages, and optionally adjust insulin-to-carbohydrate ratio (ICR) and correction factor (CF) to improve glucose control.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If users manually select medicament delivery dosages in open loop mode, then the device operates with user control and simplicity, but the dosages tend to be sub-optimal and underestimate insulin needs

Engineering Contradiction:
Improveuser controlVSAvoiddosage accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The system uses feedback from closed loop mode performance to automatically adjust open loop mode dosages. The processor compares actual medicament delivery amounts from closed loop mode with programmed open loop mode amounts, calculates differences, and generates suggestions or automatic adjustments to improve dosage accuracy while maintaining user control options

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system performs self-adjustment by automatically calculating optimal dosage amounts based on historical closed loop data. The processor programmatically adjusts the open loop mode medicament delivery amounts without requiring manual user recalculation, allowing the device to serve itself in optimizing delivery parameters

Inventive Principle:
Principle #25Self-service

2Reliability

If users increase medicament delivery dosages to compensate for underestimation, then glucose control may improve, but the risk of hypoglycemia increases

Engineering Contradiction:
Improveglucose controlVSAvoidhypoglycemia risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The feedback mechanism analyzes actual delivery amounts from closed loop mode to determine precise adjustment needs. By comparing historical data and calculating specific differences, the system provides targeted dosage adjustments that improve glucose control without excessive increases that would cause hypoglycemia

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system dynamically adjusts medicament delivery parameters based on analyzed data. The processor modifies delivery amounts, insulin-to-carbohydrate ratios, and correction factors to optimize glucose control while maintaining safety margins against hypoglycemia through data-driven parameter optimization

Inventive Principle:
Principle #35Parameter changes

3Reliability

If the device operates in closed loop mode with feedback, then optimal glucose control is achieved, but the device complexity and automation increase

Engineering Contradiction:
Improveglucose controlVSAvoidcontrol system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system provides multi-functionality by enabling both open loop and closed loop modes within a single device architecture. The processor can operate in either mode or transition between them, allowing the device to serve multiple purposes and reducing the need for separate systems for different control approaches

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS12564679B2Adjusting medicament delivery parameters in an open loop medicament delivery mode
Publication Date: 2026.03.03 INSULET CORP
  • US12564679B2 patent drawing
  • US12564679B2 patent drawing
  • US12564679B2 patent drawing

AI summary

The exemplary embodiments provide an automated approach for adjusting the medicament delivery rate to the user when operating in an open loop manner (“open mode”). The approach relies upon an insulin delivery history to the user make adjustments to the medicament delivery rate in the open mode. In particular, the exemplary embodiments may look at the medicament delivery history while the medicament delivery device is operating in a closed loop manner (“closed mode”) to determine how to adjust the open mode medicament delivery rate. It is presumed that in closed mode, the control system of the medicament device has gained knowledge over time about how to control the medicament delivery rate to produce good treatment outcomes for the user. The exemplary embodiments leverage this knowledge to adjust the open mode medicament delivery rates. Medicament bolus deliveries in open mode may also be adjusted in like fashion.